RxDoctor Payments Data

Matthew Davis

Optometrist · Newton, NCNPI 1659707230

Payments from drug & device makers

$1,590in general payments, 2019–2025

Across 72 payments — averaging $22.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson Vision Care, Inc.$418
  • Bausch & Lomb Americas Inc.$414
  • Coopervision Inc.$301
  • Sun Pharmaceutical Industries Inc.$124
  • Bausch & Lomb, A Division Of Bausch Health US, LLC$94
  • Optos, Inc.$57
  • plus $182 from 5 others

What the payments were for

  • Food & beverage$1,53396%
  • Entertainment$574%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,590 in reported general payments places this provider in the 55th percentile of 1,326 optometrist providers in North Carolina.

See all optometrist providers in North Carolina

Medicare billing

Part B allowed, 2024
$31,589
Medicare patients
182
Services billed
2,298

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RestasisCyclosporine11$13,745
LumiganBimatoprost19$8,427
Travoprost12$2,886
Tobramycin-DexamethasoneTobramycin/Dexamethasone18$893
Latanoprost60$859
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha36$347
ErythromycinErythromycin Base24$208

Paid to pharmacies, not to this prescriber.

Other optometrist in Newton

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →